Biogen SG&A Expense (Semi Annual) Analysis

Biogen, Inc. (BIIB)

177.34 -6.44 (-3.50%) USD | NASDAQ | Apr 02, 16:00

177.32 -0.02 (-0.01%) Pre-Market: 20:00

View SG&A Expense (Semi Annual) for BIIB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Eli Lilly & Co.	--
Merck & Co., Inc.	--
Apellis Pharmaceuticals, Inc.	--